Merck 2014 Annual Report Download - page 217
Download and view the complete annual report
Please find page 217 of the 2014 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
-
201
-
202
-
203
-
204
-
205
-
206
-
207 -
208 -
209 -
210 -
211 -
212 -
213 -
214 -
215 -
216 -
217 -
218 -
219 -
220 -
221 -
222 -
223 -
224 -
225 -
226 -
227 -
228
-
229
-
230
-
231
-
232
-
233
-
234
-
235
-
236
-
237
-
238
-
239
-
240
-
241
-
242
-
243
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
-
252
-
253
-
254
-
255
-
256
-
257
-
258
-
259
-
260
-
261
-
262
-
263
-
264
-
265
-
266
-
267
-
268
-
269
-
270
-
271
 |
 |
212 CONSOLIDATED FINANCIAL STATEMENTS → Notes to the Group accounts
(46) OTHER LIABILITIES
This item comprised:
€ million current non-current Dec. 31, 2014 current non-current Dec. 31, 2013
Other financial liabilities 692.9 3.2 696.1 578.9 2.2 581.1
Liabilities from derivatives
(operational) 29.0 6.4 35.4 1.5 0.6 2.1
Financial items 721.9 9.6 731.5 580.4 2.8 583.2
Accruals for personnel expenses 474.3 – 474.3 439.9 – 439.9
Deferred income 220.9 768.6 989.5 31.6 2.3 33.9
Advance payments received from
customers 15.0 – 15.0 16.0 – 16.0
Liabilities from non-income
related taxes 142.5 3.8 146.3 66.6 0.5 67.1
Non-financial items 852.7 772.4 1,625.1 554.1 2.8 556.9
1,574.6 782.0 2,356.6 1,134.5 5.6 1,140.1
As of December 31, 2014, other financial liabilities included
liabilities to related companies amounting to € 425.6 million
(2013: €373.1 million). These are mainly profit entitlements of
E. MerckKG, Darmstadt, Germany. Moreover, this item contained
liabilities to investments amounting to €3.1 million (2013: €1.6
million), interest accruals of €85.9 million (2013: €83.3 million)
as well as payroll liabilities of €65.9 million (2013: €63.6 mil-
lion). The remaining amount of €115.6 million (2013: €59.5 mil-
lion) recorded under
other financial liabilities included among
other things liabilities to
insurers as well as contractually agreed
payment obligations vis-à-vis other companies.
The increase in deferred income results from the collaboration
agreement with Pfizer Inc., USA (see Note [5]).
(47) TAX LIABILITIES
Tax liabilities and provisions for tax liabilities resulted in total
income tax liabilities of €849.8 million as of December 31, 2014
(2013: €465.1 million). The increase in tax liabilities is primarily
due to higher income tax expenses in fiscal 2014 (see Note [32]) as
well as provisions for potential tax obligations.